Stimulation suspension in response to patient discomfort or state
US10898714B2 · kind B2 · utility
10Cited by
4References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 2016 |
| Grant date | Jan 26, 2021 |
| Priority date | — |
| Expiry date | Feb 2, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61B5/1135
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Systems and methods are provided for delivering neurostimulation therapies to patients. Stimulation from an implantable medical device (IMD) may be suspended in response to detecting a patient discomfort event, such as a cough, throat irritation, or voice alteration. The suspension period may be based on at least one of a severity level of the patient discomfort event and a patient physical state, such as being asleep or lying down. Detection of a patient discomfort event may be calibrated.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.